• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CD38 和 E2F 转录因子 2 在类风湿关节炎滑膜组织中表达独特增加。

CD38 and E2F transcription factor 2 have uniquely increased expression in rheumatoid arthritis synovial tissues.

机构信息

Medical Research Center of Shandong Provincial Qianfoshan Hospital, Shandong University, Jinan, Shandong, China.

出版信息

Clin Exp Immunol. 2014 May;176(2):222-31. doi: 10.1111/cei.12268.

DOI:10.1111/cei.12268
PMID:24397353
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3992034/
Abstract

The purpose of the current study was to find novel rheumatoid arthritis (RA)-specific gene expression by simultaneously comparing the expression profiles of the synovial tissues from patients with RA, osteoarthritis (OA) and ankylosing spondylitis (AS). The Illumina Human HT-12 v4 Expression BeadChip was used to investigate the global gene expression profiles in synovial tissues from RA (n = 12), OA (n = 14) and AS (n = 7) patients. By comparing the profiles in synovial tissues from RA, OA and AS, we identified the CD38, ankyrin repeat domain 38 (ANKRD38), E2F transcription factor 2 (E2F2), craniofacial development protein 1 (CFDP1), cluster of differentiation (CD)7, interferon-stimulated exonuclease gene 20 kDa (ISG20) and interleukin-2 receptor gamma (IL)-2RG genes as differentially expressed gene expression in RA synovial tissues. The increased expression of CD38, E2F2 and IL-2RG, as revealed using real-time polymerase chain reaction (PCR) with synovial tissues from RA (n = 30), OA (n = 26) and AS patients (n = 20), was in agreement with the microarray data. Immunohistochemistry revealed significant CD38 expression and E2F2 in synovial membranes from RA patients (n = 5). The CD38(+) cells had high a percentage in the RA patients' blood (n = 103) and in the CD3(+) and CD56(+) subsets. The CD38(+) cell percentage was correlated significantly with RF level (P = 0·026) in RA patients. The IL-1α and IL-β levels were depressed significantly in the culture medium of RA synovial fibroblast cells (n = 5) following treatment with siRNAs targeting the E2F2 or CD38 genes. This study suggests that the uniquely increased expression of CD38 and E2F2 in RA synovial tissues contribute to the immunoactivation of the disease.

摘要

本研究的目的是通过同时比较类风湿关节炎(RA)、骨关节炎(OA)和强直性脊柱炎(AS)患者滑膜组织的表达谱,寻找新的 RA 特异性基因表达。我们使用 Illumina Human HT-12 v4 Expression BeadChip 来研究 RA(n=12)、OA(n=14)和 AS(n=7)患者滑膜组织的全基因表达谱。通过比较 RA、OA 和 AS 滑膜组织的表达谱,我们鉴定出 CD38、ankyrin repeat domain 38(ANKRD38)、E2F transcription factor 2(E2F2)、craniofacial development protein 1(CFDP1)、cluster of differentiation(CD)7、interferon-stimulated exonuclease gene 20kDa(ISG20)和 interleukin-2 receptor gamma(IL-2RG)是 RA 滑膜组织中差异表达的基因。使用实时聚合酶链反应(PCR)检测 RA(n=30)、OA(n=26)和 AS 患者(n=20)的滑膜组织,发现 CD38、E2F2 和 IL-2RG 的表达增加,与微阵列数据一致。免疫组织化学显示 RA 患者滑膜组织中 CD38 表达和 E2F2 明显增加(n=5)。RA 患者的血液(n=103)和 CD3+和 CD56+亚群中 CD38+细胞的比例较高。RA 患者中 CD38+细胞的比例与 RF 水平显著相关(P=0.026)。用靶向 E2F2 或 CD38 基因的 siRNA 处理 RA 滑膜成纤维细胞后,细胞培养基中 IL-1α 和 IL-β 水平显著降低(n=5)。本研究表明,RA 滑膜组织中 CD38 和 E2F2 的独特高表达有助于疾病的免疫激活。

相似文献

1
CD38 and E2F transcription factor 2 have uniquely increased expression in rheumatoid arthritis synovial tissues.CD38 和 E2F 转录因子 2 在类风湿关节炎滑膜组织中表达独特增加。
Clin Exp Immunol. 2014 May;176(2):222-31. doi: 10.1111/cei.12268.
2
E2F2 directly regulates the STAT1 and PI3K/AKT/NF-κB pathways to exacerbate the inflammatory phenotype in rheumatoid arthritis synovial fibroblasts and mouse embryonic fibroblasts.E2F2 直接调控 STAT1 和 PI3K/AKT/NF-κB 通路,加剧类风湿关节炎滑膜成纤维细胞和小鼠胚胎成纤维细胞中的炎症表型。
Arthritis Res Ther. 2018 Oct 4;20(1):225. doi: 10.1186/s13075-018-1713-x.
3
Identification of proteins with increased expression in rheumatoid arthritis synovial tissues.类风湿性关节炎滑膜组织中表达增加的蛋白质的鉴定
J Rheumatol. 2009 May;36(5):872-80. doi: 10.3899/jrheum.080939. Epub 2009 Apr 15.
4
Kinesin-like protein CENP-E is upregulated in rheumatoid synovial fibroblasts.驱动蛋白样蛋白CENP - E在类风湿性滑膜成纤维细胞中上调。
Arthritis Res. 1999;1(1):71-80. doi: 10.1186/ar13. Epub 1999 Oct 26.
5
Wnt1 inducible signaling pathway protein-3 regulation and microsatellite structure in arthritis.关节炎中Wnt1诱导信号通路蛋白-3的调控及微卫星结构
J Rheumatol. 2004 Nov;31(11):2106-14.
6
Integrative analysis reveals CD38 as a therapeutic target for plasma cell-rich pre-disease and established rheumatoid arthritis and systemic lupus erythematosus.综合分析揭示 CD38 是富含浆细胞的前期疾病和已确诊的类风湿关节炎及系统性红斑狼疮的治疗靶点。
Arthritis Res Ther. 2018 May 2;20(1):85. doi: 10.1186/s13075-018-1578-z.
7
Interleukin-18 expression in rheumatoid artheritis synovial tissue and its relation to disease activity.白细胞介素-18在类风湿性关节炎滑膜组织中的表达及其与疾病活动的关系。
Egypt J Immunol. 2007;14(2):1-10.
8
Investigating a pathogenic role for TXNDC5 in rheumatoid arthritis.研究 TXNDC5 在类风湿关节炎中的致病作用。
Arthritis Res Ther. 2011 Jul 29;13(4):R124. doi: 10.1186/ar3429.
9
Inhibition of PCSK6 may play a protective role in the development of rheumatoid arthritis.抑制前蛋白转化酶枯草溶菌素6(PCSK6)可能在类风湿关节炎的发展中起保护作用。
J Rheumatol. 2015 Feb;42(2):161-9. doi: 10.3899/jrheum.140435. Epub 2014 Nov 29.
10
The pattern-recognition receptor nucleotide-binding oligomerization domain--containing protein 1 promotes production of inflammatory mediators in rheumatoid arthritis synovial fibroblasts.模式识别受体核苷酸结合寡聚化结构域蛋白1促进类风湿性关节炎滑膜成纤维细胞中炎症介质的产生。
Arthritis Rheum. 2012 May;64(5):1329-37. doi: 10.1002/art.34318.

引用本文的文献

1
Single cell immune profiling in ankylosing spondylitis reveals resistance of CD8 T cells to immune exhaustion.强直性脊柱炎的单细胞免疫分析揭示了CD8 T细胞对免疫耗竭的抗性。
iScience. 2025 Jun 6;28(7):112715. doi: 10.1016/j.isci.2025.112715. eCollection 2025 Jul 18.
2
The , and Genes Associated with Atherosclerosis May Be Potential Diagnostic Biomarkers for Psoriasis.与动脉粥样硬化相关的 、 和 基因可能是银屑病潜在的诊断生物标志物。 你提供的原文中存在一些缺失的内容,比如基因名称部分不完整,以上是按照现有内容尽量完整翻译的结果。
J Inflamm Res. 2023 Feb 27;16:827-843. doi: 10.2147/JIR.S398862. eCollection 2023.
3
Targeting CD38 in Neoplasms and Non-Cancer Diseases.针对肿瘤和非癌症疾病中的CD38
Cancers (Basel). 2022 Aug 28;14(17):4169. doi: 10.3390/cancers14174169.
4
The CD38 glycohydrolase and the NAD sink: implications for pathological conditions.CD38 糖基水解酶和 NAD 汇:对病理状况的影响。
Am J Physiol Cell Physiol. 2022 Mar 1;322(3):C521-C545. doi: 10.1152/ajpcell.00451.2021. Epub 2022 Feb 9.
5
T-Cell Immune Imbalance in Rheumatoid Arthritis Is Associated with Alterations in NK Cells and NK-Like T Cells Expressing CD38.类风湿关节炎中的 T 细胞免疫失衡与 NK 细胞和表达 CD38 的 NK 样 T 细胞的改变有关。
J Innate Immun. 2022;14(2):148-166. doi: 10.1159/000516642. Epub 2021 Aug 24.
6
E2F2 stimulates CCR4 expression and activates synovial fibroblast-like cells in rheumatoid arthritis.E2F2刺激CCR4表达并激活类风湿性关节炎中的滑膜成纤维样细胞。
Cent Eur J Immunol. 2021;46(1):27-37. doi: 10.5114/ceji.2021.105243. Epub 2021 Apr 18.
7
The role of CD38 in HIV infection.CD38 在 HIV 感染中的作用。
AIDS Res Ther. 2021 Apr 5;18(1):11. doi: 10.1186/s12981-021-00330-6.
8
CD38: An Immunomodulatory Molecule in Inflammation and Autoimmunity.CD38:炎症和自身免疫中的免疫调节分子。
Front Immunol. 2020 Nov 30;11:597959. doi: 10.3389/fimmu.2020.597959. eCollection 2020.
9
Promising targets and drugs in rheumatoid arthritis: a module-based and cumulatively scoring approach.类风湿关节炎中有前景的靶点和药物:一种基于模块和累积评分的方法。
Bone Joint Res. 2020 Aug 2;9(8):501-514. doi: 10.1302/2046-3758.98.BJR-2019-0301.R1. eCollection 2020 Aug.
10
CD38-targeted Immuno-PET of Multiple Myeloma: From Xenograft Models to First-in-Human Imaging.CD38 靶向免疫 PET 多发性骨髓瘤:从异种移植模型到首例人体成像。
Radiology. 2020 Jun;295(3):606-615. doi: 10.1148/radiol.2020192621. Epub 2020 Apr 7.

本文引用的文献

1
The relative composition of the inflammatory infiltrate as an additional tool for synovial tissue classification.炎症浸润的相对组成作为滑膜组织分类的附加工具。
PLoS One. 2013 Aug 8;8(8):e72494. doi: 10.1371/journal.pone.0072494. eCollection 2013.
2
Gene expression analysis of rheumatoid arthritis synovial lining regions by cDNA microarray combined with laser microdissection: up-regulation of inflammation-associated STAT1, IRF1, CXCL9, CXCL10, and CCL5.通过 cDNA 微阵列结合激光显微切割分析类风湿关节炎滑膜衬里区域的基因表达:炎症相关 STAT1、IRF1、CXCL9、CXCL10 和 CCL5 的上调。
Scand J Rheumatol. 2012 May;41(3):170-9. doi: 10.3109/03009742.2011.623137. Epub 2012 Mar 9.
3
Estrogen inhibits apoptosis and promotes CC motif chemokine ligand 13 expression on synovial fibroblasts in rheumatoid arthritis.雌激素抑制类风湿关节炎滑膜成纤维细胞凋亡并促进 CC 基元趋化因子配体 13 的表达。
Immunopharmacol Immunotoxicol. 2012 Oct;34(5):852-7. doi: 10.3109/08923973.2012.664149. Epub 2012 Mar 7.
4
Identification and evaluation of novel synovial tissue biomarkers in rheumatoid arthritis by laser scanning cytometry.通过激光扫描细胞术鉴定和评估类风湿关节炎的新型滑膜组织生物标志物。
Arthritis Res Ther. 2012 Jan 17;14(1):R8. doi: 10.1186/ar3682.
5
Diagnostic and prognostic value of synovial biopsy in adult undifferentiated peripheral inflammatory arthritis: a systematic review.滑膜活检在成人未分化型外周炎性关节炎中的诊断和预后价值:一项系统评价
J Rheumatol Suppl. 2011 Mar;87:45-7. doi: 10.3899/jrheum.101074.
6
The transcriptional response of normal and rheumatoid arthritis synovial fibroblasts to hypoxia.正常及类风湿性关节炎滑膜成纤维细胞对缺氧的转录反应。
Arthritis Rheum. 2010 Dec;62(12):3584-94. doi: 10.1002/art.27750.
7
Early and long-standing rheumatoid arthritis: distinct molecular signatures identified by gene-expression profiling in synovia.早期和长期的类风湿关节炎:滑膜基因表达谱分析鉴定的独特分子特征。
Arthritis Res Ther. 2009;11(3):R99. doi: 10.1186/ar2744. Epub 2009 Jun 29.
8
CD38 is constitutively expressed in the nucleus of human hematopoietic cells.CD38在人类造血细胞的细胞核中持续表达。
J Cell Biochem. 2008 Oct 15;105(3):905-12. doi: 10.1002/jcb.21887.
9
Distinctive gene expression signatures in rheumatoid arthritis synovial tissue fibroblast cells: correlates with disease activity.类风湿性关节炎滑膜组织成纤维细胞中独特的基因表达特征:与疾病活动的相关性。
Genes Immun. 2007 Sep;8(6):480-91. doi: 10.1038/sj.gene.6364400. Epub 2007 Jun 14.
10
Potential new targets in arthritis therapy: interleukin (IL)-17 and its relation to tumour necrosis factor and IL-1 in experimental arthritis.关节炎治疗中的潜在新靶点:白细胞介素(IL)-17及其在实验性关节炎中与肿瘤坏死因子和IL-1的关系。
Ann Rheum Dis. 2006 Nov;65 Suppl 3(Suppl 3):iii29-33. doi: 10.1136/ard.2006.058529.